Federal Court Judge Weighing Four Factors In Plavix Preliminary Injunction Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal Judge Sidney Stein said he will weigh four factors to determine whether to issue a preliminary injunction in favor of Sanofi-Aventis and Bristol-Myers Squibb blocking sales of generic clopidogrel by Apotex
You may also be interested in...
Apotex Seeks $4 Bil. Bond From Sanofi/Bristol At Plavix Injunction Hearing
During an Aug. 18 hearing, Apotex says a preliminary injunction should not include a recall of generic clopidogrel.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.